Tegoprazan vs Lansoprazole for Bleeding Peptic Ulcer
Treatments studied
Part of Digestive system clinical trials.
This trial compares two acid-reducing medicines—Tegoprazan and Lansoprazole—to see which works better for stopping bleeding from a peptic ulcer. If you have a confirmed upper GI bleed from an ulcer, this study may help find the best treatment for you.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with an upper GI bleed from a peptic ulcer (seen on an endoscopy).
- You are not allergic to either Tegoprazan or Lansoprazole.
- You do not have stomach or duodenal cancer, and you are not pregnant.
- You have not had H. pylori infection treatment that failed.
- You do not have chronic kidney disease, advanced liver cirrhosis, and you are not drinking alcohol or on chemotherapy.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a newer drug, tegoprazan, works as well as the standard drug lansoprazole for healing bleeding ulcers in the stomach or small intestine. You will get one of these drugs for 14 days and have a follow-up endoscopy to check healing.
This trial tests two medicines that lower stomach acid to help stop bleeding from the stomach or intestines. It aims to find which one works better for people with this type of bleeding.
This trial compares two types of acid-reducing medicines to see which is better at preventing re-bleeding in people who have had severe ulcer bleeding. If you qualify, you would receive either a new acid blocker or a double dose of a standard acid reducer.
This study tests whether a newer medicine, tegoprazan, works better than an older one, pantoprazole, for treating heartburn and acid reflux. Both are stomach acid reducers. You may be able to join if you have been diagnosed with GERD and your symptoms have lasted for at least three months.
This trial compares two different types of stomach-acid-lowering medicines — tegoprazan and a proton pump inhibitor (PPI) — to see which works better at clearing H. pylori infection. It's for people who have not been treated for H. pylori before and can safely have a stomach scope.
This trial compares an IV “acid-suppressing” medicine (PPI infusion) with acid pills (oral PPIs) after doctors treat a bleeding peptic ulcer endoscopically. It may help prevent re-bleeding by keeping stomach acid low while the ulcer heals.
Hear when a new Peptic Ulcer Bleeding trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.